DNA methylation profiles in whole blood samples from 77 patients with CN-AML in The Cancer Genome Atlas (LAML cohort) were analyzed. Individual 5’-cytosine-phosphate-guanine-3’ (CpG) sites were ...
Integration of AI with image-based genomics, consolidation towards integrated platforms, and growing focus on companion diagnostics bolster growthDublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The ...
The Immune Atlas identifies immune signatures in MM, enhancing outcome prediction and guiding personalized therapies by ...
Health on MSN
The 3 Stages of Multiple Myeloma
Multiple myeloma is a rare type of blood cancer that starts in your plasma cells. Your plasma cells are a type of white blood cell inside your bone marrow, the soft inner part of your bones. If you ...
Bionano Genomics, Inc. announced a groundbreaking study published in Modern Pathology, which highlights the effectiveness of optical genome mapping (OGM) in detecting bone and soft tissue tumors. This ...
DUBLIN--(BUSINESS WIRE)--The "Cytogenetics - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to Research and Markets' offering. This report deals with cytogenetics ...
AML is a hematologic cancer that is clinically heterogeneous, with a wide range of clinical outcomes. DNA methylation changes are a hallmark of AML but are not routinely used as a criterion for risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results